Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients ↓	Dosage	Form	Price
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 50mg	50mg	Tablet, coated	15,808,184 L.L
J02AC03	VFEND	B	Voriconazole - 200mg	200mg	Tablet, film coated	51,904,550 L.L
J02AC03	VIROZOLE 200	G	Voriconazole - 200mg	200mg	Tablet, film coated	47,909,207 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Tablet, coated	41,794,841 L.L
J02AC03	V-FEND	B	Voriconazole - 200mg	200mg	Injectable powder for solution	8,078,564 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Injectable powder for solution	5,841,683 L.L
A12AX	VITAQPLUS	G	Vitamin K2 - 0.05mg, Colecalciferol - 400IU, Calcium - 300mg		Tablet	2,500,891 L.L
A11CC05	VIDROP	G	Vitamin D3 - 100IU/drop	100IU/drop	Drops	346,711 L.L
A11CC05	VITEX D3	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	447,500 L.L
A11CC05	VIT-X-FORTE	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
A11DB	VITANOR	G	Vitamin B1 - 250mg, Vitamin B6 - 250mg, Vitamin B12 - 500mcg		Tablet, film coated	946,065 L.L
A11BA	VITALIPID N INFANT	B	Vitamin A - 230IU/ml, Vitamin D2 - 40IU/ml, Vitamin E - 0.7IU/ml, Vitamin K1 - 20mcg/ml		Injectable concentrate for solution	2,448,481 L.L
A10BH02	VILDAVITAE	G	Vildagliptin - 50mg	50mg	Tablet	665,202 L.L
A10BH02	VILDIAB	G	Vildagliptin - 50mg	50mg	Tablet	806,306 L.L
A10BH02	VLUDIN	G	Vildagliptin - 50mg	50mg	Tablet	767,910 L.L
A10BH02	VLUDIN	G	Vildagliptin - 50mg	50mg	Tablet	767,910 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 75mg	75mg	Capsule, prolonged release	584,571 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	895,895 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	1,343,843 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 37.5mg	37.5mg	Capsule, prolonged release	538,881 L.L
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	944,529 L.L
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	1,416,794 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 75mg	75mg	Tablet, prolonged release	1,075,074 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	383,955 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 150mg	150mg	Tablet, prolonged release	987,724 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4		Tablet	190,943,809 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	707,858,935 L.L
L01XX52	VENCLEXTA	B	Venetoclax - 100mg	100mg	Tablet	L.L
D02AC	VASELINE PURE	G	Vaseline pure - 20g	20g	Ointment	103,668 L.L

...